drugset / Trial / NCT01492556
Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer
Phase 2
Unknown
100 enrolled
Chinese Academy of Medical Sciences
Beijing Chao Yang Hospital · collabBeijing Hospital of the Ministry of Health · collabChina-Japan Friendship Hospital · collabGuangxi Cancer Hospital · collabHenan Cancer Hospital · collabInternational Peace Maternity and Child Health Hospital · collabPeking Union Medical College Hospital · collabPeking University Cancer Hospital & Institute · collabShanghai Putuo District Center Hospital · collabThe First Affiliated Hospital of Dalian Medical University · collabThe Second Affiliated Hospital of Harbin Medical University · collabXinjiang Medical University · collabZhejiang Cancer Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Etoposide Monotherapy is effective and safe in the treatment of recurrent or metastatic breast cancer in Chinese female patients.
Timeline
- Start
- 2011-12
- Primary completion
- 2014-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etoposide | Small molecule | 60 mg/m2 | Oral |